Pressure Reduction for Pharmaceutical

Cavitation control in pharmaceutical systems

Pharmaceutical facilities depend on high-purity water and clean utility systems where flow and pressure must be controlled without introducing unnecessary noise, vibration, or equipment wear. Purified water loops, WFI distribution, CIP supply, and pump recirculation lines can develop cavitation where pressure drop is concentrated.

Key considerations

• Surface damage. Cavitation can erode wetted surfaces at or near the point of vapor collapse. In high-purity service, surface damage can become a water-quality concern, not only a maintenance concern.
• Elevated water temperature. Warm purified water and WFI carry higher vapor pressure than cold water, which narrows the margin against cavitation at any given downstream pressure.
• Occupied spaces. Utility piping in pharmaceutical plants often runs through or near production and lab areas, where cavitation-related noise and vibration can be more disruptive than in many industrial settings.
• Practical evaluation. Actual operating data — pressures, temperature, flow, fluid properties, and piping layout — is required to determine whether cavitation risk is present.

Managing pressure reduction and energy dissipation can help reduce cavitation-related noise, vibration, and wear in systems built around cleanliness and repeatability.

‍